Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Small Cell Lung Carcinoma 1

Interventions

Specimen Handling 278 Magnetic Resonance Spectroscopy 233 pembrolizumab 227 Carboplatin 187 Cisplatin 153 Biopsy 148 Cyclophosphamide 143 Paclitaxel 133 Nivolumab 122 Gemcitabine 113 Bevacizumab 104 Radiotherapy 92 Dexamethasone 86 Pemetrexed 83 fludarabine 77 Fluorouracil 76 Docetaxel 75 Doxorubicin 74 atezolizumab 71 Radiation 71 Leucovorin 70 Rituximab 67 Oxaliplatin 66 venetoclax 61 durvalumab 61 Prednisone 60 Vincristine 56 Cetuximab 56 Lenalidomide 54 Etoposide 54

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × MLN 8237 × 30 days × Clear all

NCT06095505 2026-06-05

ALISCA-Lung1

Puma Biotechnology, Inc.

Phase 2 Recruiting

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡